This is a working overview of lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-07. Anything still debated is marked as such rather than presented as settled.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Nuclear magnetic resonance (NMR) is one of the most common methods to determine the physical and chemical properties of atoms by detecting the radio frequency absorbed and subsequent relaxation of nuclei in a magnetic field. This is one of the most commonly used characterization techniques and has applications in numerous fields. Primarily, the strong magnetic fields are generated by supercooling electromagnets, although there are spectrometers that do not require cryogens. In traditional superconducting solenoids, liquid helium is used to cool the inner coils because it has a boiling point of around 4 K at ambient pressure. Inexpensive metallic superconductors can be used for the coil wiring. So-called high-temperature superconducting compounds can be made to super conduct with the use of liquid nitrogen, which boils at around 77 K. Magnetic resonance imaging (MRI) is a complex application of NMR where the geometry of the resonances is deconvoluted and used to image objects by detecting the relaxation of protons that have been perturbed by a radio-frequency pulse in the strong magnetic field. This is most commonly used in health applications. Cryogenic electron microscopy (cryoEM) is a popular method in structural biology for elucidating the structures of proteins, cells, and other biological systems. Samples are plunge-frozen into a cryogen such as liquid ethane cooled by liquid nitrogen, and are then kept at liquid nitrogen temperature as they are inserted into an electron microscope for imaging. Electron microscopes are also themselves cooled by liquid nitrogen.
Pancetta – Italian bacon is pork belly meat that is salt cured and contains peppercorns. Associated with Italy, pancetta varies by region. It is often cubed, as lardon. It is also produced in Spain. Pastirma – a highly seasoned, air-dried cured beef of Anatolian origin, which is now part of the cuisines of the former Ottoman countries. Pastrami – a popular delicatessen meat usually made from beef in Romania, and also from pork and mutton. Like corned beef, pastrami was originally created as a way to preserve meat before modern refrigeration. Pemmican – a historic food, pemmican is a concentrated mixture of fat and protein used as a nutritious food. Pepperoni – an American variety of salami, usually made from cured pork and beef. Pepperoni is characteristically soft, slightly smoky, and bright red in color. Pinnekjøtt – in Norway, a main course dinner dish of lamb or mutton, its preparation uses a traditional method for food preservation utilizing curing, drying and in some regions also smoking. Pitina – an Italian cold cut with origin in the mountain valleys of Tramonti di Sopra and River Cellina of the province of Pordenone in northeastern Italy. Presunto – the name given to dry-cured ham from Portugal. Many varieties exist. Prosciutto – a dry-cured ham that is usually thinly sliced and served uncooked; this style is called prosciutto crudo in Italian and is distinguished from cooked ham, prosciutto cotto.
A bill of health is a document issued by the consul or the public authorities of the port which a ship sails from, descriptive of the health of the port at the time of the vessel's clearance. A clean bill of health certifies that at the date of its issue no infectious disease was known to exist either in the port or its neighbourhood. A suspected or touched bill of health reports that rumours were in circulation that an infectious disease had appeared but that the rumour had not been confirmed by any known cases. A foul bill of health or the absence of a clean bill of health implies that the place the vessel cleared from was infected with a contagious disease. The two latter cases would render the vessel liable to quarantine. Another category of biosecurity measures adopted by border control organisations is mandatory vaccination. As a result of the prevalence of Yellow Fever across much of the African continent, a significant portion of countries in the region require arriving passengers to present an International Certificate of Vaccination or Prophylaxis (Carte Jaune) certifying that they have received the Yellow Fever vaccine. A variety of other countries require travelers who have visited areas where Yellow Fever is endemic to present a certificate to clear border checkpoints, as a means of preventing the spread of the disease. Before the emergence of COVID-19, Yellow Fever was the primary human disease subject to de facto vaccine passport measures by border control authorities worldwide.
=== Postmarketing surveillance === Until a vaccine is in use amongst the general population, all potential adverse events from the vaccine may not be known, requiring manufacturers to conduct Phase IV studies for postmarketing surveillance of the vaccine while it is used widely in the public. The WHO works with UN member states to implement post-licensing surveillance. The FDA relies on a Vaccine Adverse Event Reporting System to monitor safety concerns about a vaccine throughout its use in the American public.
=== Cosmetics and medicine === In nutraceutical industries, Arthrospira (Spirulina) and Chlorella are the most important species in commercialization as health foods and nutrition supplements with various health benefits including enhancing immune system activity, anti-tumor effects, and animal growth promotion, due to their abundant proteins, vitamins, active polysaccharides, and other important compounds. Microalgal carotenoids, with β-carotene from Dunaliella and astaxanthin from Haematococcus are commercially produced in large scale processes. Microalgal derived products are currently successfully developed for uses in cosmetics and pharmaceutical products. Examples include the polysaccharides from cyanobacteria used in personal skin care products and extracts of Chlorella sp. which contain oligopeptides that can promote firmness of the skin. In the pharmaceutical industries drug candidates with anti-inflammatory, anticancer, and anti-infective activities have been identified. For instance, adenosine from Phaeodactylum tricornutum, can act as an anti-arrhythmic agent for the treatment of tachycardia and the green algal metabolite caulerpin is featured in studies of anti-tuberculosis activities. Moreover, some extracellular polysaccharides from microalgae have various bioactivities involving antitumor, anti-inflammatory, and antiviral activity, providing promising prospects for pharmaceutical applications.
Sources: en.wikipedia.org
N0 is the initial quantity of the substance that will decay (this quantity may be measured in grams, moles, number of atoms, etc.), N(t) is the quantity that still remains and has not yet decayed after a time t, t½ is the half-life of the decaying quantity, τ is a positive number called the mean lifetime of the decaying quantity, λ is a positive number called the decay constant of the decaying quantity. The three parameters t½, τ, and λ are directly related in the following way:
According to the first option, the spent nuclear fuel is considered complete waste. After an interim storage (wet and dry), all the used fuel is directly disposed of in a deep geological repository. Several geological media and repository designs are being studied according to different natures of fuel and their burnup, radioactive inventory and decay heat generation. The assessment of a geological disposal is based on the multi-barrier approach, which combines multiple effects of engineered and natural barriers in order to delay potential long-lived radionuclide migrations to the biosphere over time. Reprocessing is the alternative option for the spent fuel after a long interim storage. The used fuel is not considered waste anymore but a future energy resource. A large amount of fertile uranium (
=== Provincial–municipal relations === In September 2018, Ford announced that he would use the Canadian Charter of Rights and Freedoms' "notwithstanding" clause to override the ruling of a Superior Court judge which said that Ford's legislation, decreasing the size of Toronto City Council just before the municipal election, was unconstitutional. As Ontario's AG, Mulroney voted in support of the Ford government's use of Section 33 of the Canadian Charter of Rights and Freedoms. According to the Globe and Mail, "constitutional experts and politicians of all parties" criticized her decision as a violation of the sanctity of the judicial process as Attorney General. In October 2020, the Ford government passed the Supporting Ontario’s Recovery Act, 2020, which included a section that banned municipalities in the province from using ranked ballots for their mayoral and city council elections. The move came as multiple cities in the province were planning to switch from first-past-the-post to ranked ballots for the 2022 local elections. In 2022, the government passed the Strong Mayors, Building Homes Act, which granted extra powers to the mayor of Toronto and the mayors of other designated municipalities within their mayor–council governments. The Ford government's Better Regional Governance Act, 2026 gives the province power to appoint chairs/wardens in many regional governments, including in Peel Region, the Regional Municipality of Durham, the Waterloo Regional Municipality, and the Regional Municipality of York.
== Miscellaneous == It has been suggested that MAF can be formed by probiotic bacteria in a yoghurt medium. This probiotic mixture has been found to be helpful in various immune disturbances including ME/CFS.
== Background == North Korea borders China and South Korea, two countries with early outbreaks. China is one of North Korea's closest allies, most important trading partner, and a source of tourists. The Chinese-North Korean border is porous, in contrast to the heavily militarized border between North and South Korea. However, suspected COVID-19 cases in the two Chinese provinces bordering North Korea (Liaoning and Jilin) have been low. Diplomatically and economically isolated, North Korea is an impoverished country with a weak healthcare system and is subject to sanctions, rendering it vulnerable in the event of an outbreak. In March 2020, there was concern that the country's widespread malnutrition could exacerbate the spread of COVID-19. In April, North Korean public health official Pak Myong-su said that if the disease spread in North Korea, "a serious disaster could not be avoided". The North Korean government is secretive, and the North Korean media is tightly controlled, making it difficult for observers to determine what is going on in the country. Historically, North Korea has restricted travel in the face of epidemics abroad, such as SARS in 2003 and the Western African Ebola virus epidemic in 2014. It eradicated measles in 2018, having a very efficient vaccination program managed by the Central Hygiene and Anti-Epidemic Institute, and the Hygiene and Anti-Epidemic Station, assisted by UNICEF and the World Health Organization (WHO). Given the supply of COVID-19 vaccines, the program could vaccinate the entire population with a first dose within weeks.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.